Clinical relevance of plasma EBV DNA as a biomarker for nasopharyngeal carcinoma in non-endemic areas: A multicenter study in southwestern China-Reference-Cited by-同舟云学术

Clinical relevance of plasma EBV DNA as a biomarker for nasopharyngeal carcinoma in non-endemic areas: A multicenter study in southwestern China

Published:2023-02 Issue: Volume:541 Page:117244
ISSN:0009-8981
Container-title:Clinica Chimica Acta
language:en
Short-container-title:Clinica Chimica Acta

Author:

He Qiao,Zhou Yi,Zhou Jie,Zhao Dan,Li Luona,Li Xianbing,Huang Yecai,Wang Qiuju,Zou Haiming,Zhang Kaijiong,Li Yuping,Wang Zuo,Deng Yao,Meng Fanping,Ying Binwu,Yang Mu,Wang Dongsheng

Publisher

Elsevier BV

Subject

Biochemistry (medical),Clinical Biochemistry,Biochemistry,General Medicine

Reference47 articles.

1. Epstein-Barr Virus Mediated Signaling in Nasopharyngeal Carcinoma Carcinogenesis;Richardo;Cancers (Basel),2020

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

3. Genome sequencing analysis identifies Epstein-Barr virus subtypes associated with high risk of nasopharyngeal carcinoma;Xu;Nat Genet,2019

4. The molecular march of primary and recurrent nasopharyngeal carcinoma;Campion;Oncogene,2021

5. Epstein-Barr Virus Epithelial Cancers-A Comprehensive Understanding to Drive Novel Therapies;Han;Front Immunol,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment and validation of circulating cell-free DNA signatures for nasopharyngeal carcinoma detection;eBioMedicine;2024-10

2. Circulating tumor cells: a valuable indicator for locally advanced nasopharyngeal carcinoma;European Archives of Oto-Rhino-Laryngology;2024-05-11

3. Nasopharyngeal carcinoma cell screening based on the electroporation-SERS spectroscopy;Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy;2024-03

4. Precision Medicine for Nasopharyngeal Cancer—A Review of Current Prognostic Strategies;Cancers;2024-02-24

5. A promising predictive biomarker combined EBV NDA with PNI for nasopharyngeal carcinoma in nonendemic area of China;Scientific Reports;2023-07-20